Name: IOVA Balance Sheet - Iovance Biotherapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IOVA - Iovance Biotherapeutics, Inc.

USD | NASDAQ | Healthcare

IOVA Balance Sheet - Iovance Biotherapeutics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Cash And Short Term Investments
Cash And Equivalents	163.1	115.7	114.9	231.7	78.2	67.3	14.0	82.2	145.4	106.7	33.6	44.9	19.7	0.0	0.5	1.3	0.0
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	133.9	208.1	165.0	240.1	426.2	562.1	293.1	386.4	0.0	59.8	70.1	0.0	-	-	-	-	-
Cash And Short Term Investments	297.0	323.8	279.9	471.8	504.4	629.4	307.1	468.5	145.4	166.5	103.7	44.9	19.7	0.0	0.5
Receivables
Accounts Receivable	82.4	69.3	0.2	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	51.7	51.5	10.4	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	179.9	145.1	141.9	122.0	109.6	64.7	13.0	6.6	5.5	4.5	2.8	1.6	0.0	-
Current Liabilities
Accounts Payable	22.2	27.5	33.1	26.6	27.4	13.5	15.6	2.7	1.2	0.9	1.0	1.2	0.4	1.1	0.2
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Cash And Short Term Investments
Cash And Equivalents	196.5	163.1	158.1	132.5	171.7	115.7	164.2	228.7	134.2	114.9	267.7	230.0	543.5	231.7	118.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	58.4	51.7	51.7	49.8	65.5	51.5	38.6	27.9	17.6	10.4	9.2	9.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	12.9	11.6	9.8	11.5	15.9	12.4	6.7	10.2	11.5	17.5	12.0	14.2	11.5	7.3	9.7	7.1	7.8	3.5
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	466.5	442.7	429.1	422.5	512.6	457.0	498.6	482.3	385.5	307.8	382.6	274.9	637.8	479.1	369.9	431.6

Non-Current Assets
Property, Plant & Equipment Gross	183.8	179.9	172.0	164.6	150.3	145.1	149.3	144.8	142.7	141.9	138.4	134.9	129.3	122.0	114.7	112.6	112.0	109.6	95.4	86.4	78.7	64.7	-	-	-	-	-	-	-	-	-	-	-	-	5.4	5.1	5.1	4.5	-	-
Accumulated Depreciation	52.4	48.8	45.3	42.1	38.8	36.0	36.8	33.9	30.9	27.9	25.2	22.3	19.4	16.7	13.9	11.5	9.3
Property,Plant & Equipment Net	131.4	131.1	126.7	122.5	111.6	109.1	112.5	111.0	111.8	114.0	113.1	112.5	109.9	105.2	100.7	101.2
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	27.7
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	269.1	279.3	285.2	296.3	285.4	282.4	306.6	295.3	294.3	229.3	223.6	235.5	-	-	-	-	-
Operating Lease Right Of Use Assets	44.4	45.9	48.8	49.9	50.9	55.2	66.7	69.1	71.5	62.5	66.3	67.6	70.4	73.0	68.3	70.8
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	8.3	8.2	9.3	10.3	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.9	1.3
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	925.7	913.2	904.9	907.4	966.7	910.4	991.1	964.3	869.8	780.4	852.3	757.3	824.8	664.0	545.9	610.9	701.3

Current Liabilities
Accounts Payable	37.5	22.2	31.2	32.0	28.5	27.5	31.7	20.4	25.7	33.1	19.3	31.2	31.6	26.6	24.3	20.0	20.5	27.4	12.2	21.9	13.4	13.5	24.8	10.2	10.6	15.6	9.9	12.8	7.6	2.7	6.0	5.2	6.6	1.2	2.9	3.7	2.2	0.9	0.2	0.7
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	2.9	4.0	6.3	7.1	8.5	12.9	11.6	11.4	11.1	7.8	10.5	10.9	12.6	12.6	7.2	6.5
Accrued Expenses	88.1	111.2	87.3	89.1	84.7	81.9	74.8	61.8	46.4	69.4	61.2	46.6	43.1	52.3	47.8	37.7	48.9	56.8
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	129.4	138.4	125.8	129.2	122.7	122.3	118.1	93.6	83.2	110.3	91.0	88.6	87.3	91.5	79.2

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	43.9	44.4	45.2	45.1	44.2	44.4	66.4	69.2	72.3	67.1	68.0	68.8	69.6	71.9	71.9	73.0
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	30.6	31.8	31.7	34.7	32.0	32.3	32.2	31.9	33.3	17.3	18.3	20.2	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	74.5	76.2	76.9	79.8	76.2	77.7	99.6	102.1	106.6	85.4	87.4	90.1	70.6	72.9	72.9	74.0
Total Liabilities	203.9	214.6	202.7	208.9	198.9	200.0	217.7	195.8	189.8	195.7	178.3	178.7	157.9	164.3	152.2	138.2

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional Paid In Capital	3,563.7	3,457.7	3,389.8	3,290.0	3,262.3	3,096.0	3,063.2	2,990.5	2,805.2	2,594.4	2,579.1	2,360.5	2,342.7	2,068.9	1,858.8	1,838.8
Retained Earnings	(2,854.6)	(2,775.5)	(2,703.6)	(2,612.4)	(2,500.7)	(2,384.6)	(2,306.0)	(2,222.5)	(2,125.4)	(2,012.4)	(1,896.0)	(1,782.2)	(1,675.7)	(1,568.3)	(1,463.0)	(1,363.4)	(1,264.1)
Accumulated Other Comprehensive Income	12.7	16.4	16.1	20.9	6.3	(1.0)	16.2	0.5	0.1	2.5	(9.1)	0.3	(0.1)	(0.9)	(2.0)	(2.7)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	721.8	698.6	702.3	698.5	767.9	710.4	773.5	768.5	680.0	584.6	674.0	578.6	666.9	499.6	393.7	472.7	552.0
Total Equity	721.8	698.6	702.3	698.5	767.9	710.4	773.5	768.5	680.0	584.6	674.0	578.6	666.9	499.6	393.7	472.7	552.0	621.7

Receivables
Accounts Receivable	81.8	82.4	66.8	59.9	70.9	69.3	55.8	31.6	0.2	0.2	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	337.1	304.3	303.3	293.3	390.0	334.7	380.5	388.6	302.3	197.5	291.6	186.2	550.5	387.6	290.6	367.4	412.9	418.8
Book Value	721.8	698.6	702.3	698.5	767.9	710.4	773.5	768.5	680.0	584.6	674.0	578.6	666.9	499.6	393.7	472.7	552.0	621.7
Tangible Book Value	452.7	419.3	417.1	402.2	482.5	428.0	466.8	473.2	385.7	355.4	450.4	343.1	-	-	-	-	-